Please check your internet connection and try again.
# Dexamethasone in Chronic ITP
## Overview
Dexamethasone is a potent synthetic glucocorticoid with minimal mineralocorticoid activity. In Immune Thrombocytopenia (ITP), it is utilized for its rapid immunosuppressive and anti-inflammatory effects to elevate platelet counts.
## Primary Indications
First-line (often pulse therapy) and second-line treatment for ITP to induce remission or manage exacerbations.
## Adult Dosing
* **Standard Pulse Regimen:** 40 mg orally once daily for 4 consecutive days.
* **Cycles:** This 4-day cycle may be repeated every 14–28 days depending on the clinical response and institutional protocol.
## Pediatric Dosing
* **Pulse Regimen:** 40 mg/m²/day (maximum 40 mg/day) orally for 4 consecutive days.
* **Alternative:** Some pediatric protocols utilize 28 mg/m² (maximum 40 mg/day) for 4 days.
* *Note:* Dosing highly dependent on institutional hematology guidelines.
## Dose Adjustments
* **Renal/Hepatic Impairment:** No specific dose adjustments are typically required for short-term pulse therapy; however, monitor for increased side effects.
* **Tapering:** While high-dose pulses are often stopped abruptly, long-term use requires a formal steroid taper to prevent adrenal insufficiency.
## Contraindications
* Systemic fungal infections.
* Hypersensitivity to dexamethasone or any component of the formulation.
* Administration of live or attenuated vaccines (during immunosuppressive doses).
## Adverse Effects
* **Common:** Insomnia, mood swings (irritability, anxiety, psychosis), hyperglycemia, increased appetite, and dyspepsia.
* **Serious:** Severe infection, hypertension, aseptic necrosis of bone (rare with short pulses), and gastric ulceration.
## Key Drug Interactions
* **Anticoagulants/Antiplatelets:** Increased risk of bleeding/GI ulceration.
* **CYP3A4 Inducers (e.g., Phenytoin, Rifampin):** May decrease dexamethasone efficacy.
* **Fluoroquinolones:** Increased risk of tendon rupture.
* **NSAIDs:** Increased risk of gastrointestinal toxicity.
## Monitoring
* **Baseline:** CBC with differential, glucose, blood pressure.
* **Ongoing:** Platelet count monitoring to evaluate response (nadir is typically reached within 7–14 days). Monitor for clinical signs of infection, hyperglycemia, and neuropsychiatric changes.
## Clinical Pearls
* **Rapid Action:** Dexamethasone is often preferred over prednisone for ITP pulses due to its superior central nervous system penetration and faster onset of thrombocytopenia correction.
* **GI Protection:** Consider the use of a proton pump inhibitor (PPI) or H2-receptor antagonist while on pulse therapy to reduce gastric irritation.
* **Administration:** Take with food to minimize GI upset.
* **Refractory Cases:** Dexamethasone is generally not effective as a long-term maintenance agent; transition to other therapies (e.g., TPO-RAs, rituximab, or splenectomy) if patients are steroids-dependent.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical protocols vary by institution. Always verify specific dosing, safety data, and contraindications via official prescribing information or current institutional clinical guidelines before prescribing or administering medication.
